Katherine Ory
Impact in
- Oncology top 5%
- Cancer-related Molecular Pathways
- Biotechnology top 10%
- Cancer Research and Treatments
Papers in
-
- RNA modifications and cancer 3
- DNA Repair Mechanisms 1
- Oncology 3
- Cancer-related Molecular Pathways 3
- Co-authors
- Thierry Soussi (3 shared papers)Yann Legros (2 shared papers)Beata Schlichtholz (1 shared paper)Richard Lubin (1 shared paper)Sylvie Chevillard (6 shared papers)Céline Levalois (4 shared papers)Nicolas Ugolin (2 shared papers)Philippe Vielh (1 shared paper)
- Journals
- International Journal of Cancer (2 papers)Journal of Radiation Research (1 paper)Clinical Cancer Research (1 paper)Breast Cancer Research and Treatment (1 paper)The EMBO Journal (1 paper)
- Partner nations
- FranceUnited StatesSwitzerland
In The Last Decade
Katherine Ory
9 papers receiving 673 citations
Peers
Comparison fields: 5 of 74
- Oncology 391
- Biotechnology 88
- Cancer Research 136
- Otorhinolaryngology 23
- Endocrinology, Diabetes and Metabolism 78
Countries citing papers authored by Katherine Ory
This map shows the geographic impact of Katherine Ory's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine Ory with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine Ory more than expected).
Fields of papers citing papers by Katherine Ory
This network shows the impact of papers produced by Katherine Ory. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine Ory. The network helps show where Katherine Ory may publish in the future.
Co-authors
The 22 scholars most cited alongside Katherine Ory, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 312 | |
| 2 | 1994 | 199 | |
| 3 | 2004 | 99 | |
| 4 | 2001 | 36 | |
| 5 | 2004 | 25 | |
| 6 | 2011 | 11 | |
| 7 | Down-regulation of telomerase activity after progesterone treatment of human breast cancer cells: essential role of the cell cycle status. | 2002 | 10 |
| 8 | 1999 | 6 | |
| 9 | 2006 | 3 |
About Katherine Ory
Katherine Ory is a scholar working on Molecular Biology, Oncology, Toxicology, Radiology, Nuclear Medicine and Imaging and Endocrinology, Diabetes and Metabolism, having authored 9 papers that have together received 701 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (3 papers), RNA modifications and cancer (3 papers), Estrogen and related hormone effects (2 papers), Bioactive Compounds and Antitumor Agents (2 papers), Effects of Radiation Exposure (2 papers), Thyroid Cancer Diagnosis and Treatment (2 papers), DNA Repair Mechanisms (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Oncology (391 citations), Biotechnology (88 citations), Cancer Research (136 citations), Otorhinolaryngology (23 citations) and Endocrinology, Diabetes and Metabolism (78 citations). Katherine Ory has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include Thierry Soussi, Yann Legros, Beata Schlichtholz, Richard Lubin, Sylvie Chevillard, Céline Levalois, Nicolas Ugolin, Philippe Vielh, Adel K. El‐Naggar and Gary L. Clayman. Their work appears in journals such as International Journal of Cancer, Journal of Radiation Research, Clinical Cancer Research, Breast Cancer Research and Treatment and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.